WP
MRNA icon

Woodline Partners’s Moderna MRNA Stock Holding History

Woodline Partners’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.4M Buy
219,634
+8,161
+4% +$422K 0.05% 430
2026
Q1 		$10.7M Buy
211,473
+6,764
+3% +$316K 0.04% 495
2025
Q4 		$6.04M Sell
204,709
-43,064
-17% -$1.17M 0.02% 586
2025
Q3 		$6.4M Buy
247,773
+800
+0.3% +$22.3K 0.03% 518
2025
Q2 		$6.81M Buy
246,973
+2,641
+1% +$69.5K 0.04% 506
2025
Q1 		$6.93M Buy
244,332
+101,809
+71% +$3.61M 0.05% 428
2024
Q4 		$5.93M Buy
142,523
+10,968
+8% +$524K 0.04% 454
2024
Q3 		$8.79M Buy
+131,555
New +$12.1M 0.07% 320

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Woodline Partners's MRNA Position: Q2 2026 in Review

Woodline Partners increased its Moderna (MRNA) stake by 3.9% in Q2 2026, buying an estimated $422K and bringing the position to 219,634 shares worth $15.4M. The position accounts for 0.05% of the portfolio, ranked #430.

Woodline Partners first reported a position in MRNA in Q3 2024 and has held it in 8 quarters since. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Woodline Partners held 219,634 shares of Moderna worth $15.4M as of Q2 2026.
  • Woodline Partners bought 8,161 Moderna shares in Q2 2026, an estimated $422K.
  • Moderna made up 0.05% of Woodline Partners's portfolio in Q2 2026, its #430 holding.
  • Woodline Partners first reported a position in Moderna in Q3 2024 and has held it in 8 quarters since.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.